Announced Thu, 10 Sept, 2026 · 14:52 IST
NCLT admits insolvency case against Shilpa Medicare subsidiary FTF Pharma
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.6%1-day move
₹965.00
prior close
₹949.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-0.2-1.4-0.6-5.6-3.1-0.9+6.5+6.9+6.7———
Up moveDown movePending
AI summary
NCLT Ahmedabad has admitted an insolvency petition by Immacule Lifesciences against Shilpa Medicare's wholly owned subsidiary FTF Pharma Private Limited over an operational debt of about Rs 2.18 crore. Corporate Insolvency Resolution Process has commenced, moratorium imposed, and an Interim Resolution Professional appointed. The order relates only to the subsidiary; no violation alleged against the listed entity. Impact on parent not yet quantifiable.
Likely market impact
Negative for subsidiary operations; impact on parent not ascertainable yet but may weigh on consolidated financials.